Oral Health-Related Quality of Life Using EORTC QLQ-H&N35 in Head and Neck Cancer Survivors Within the First Year Following Treatment: a Cross-Sectional Study in Egypt
Launched by AIN SHAMS UNIVERSITY · Mar 23, 2025
Trial Information
Current as of April 30, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the quality of life related to oral health in survivors of head and neck cancer in Egypt, specifically within the first year after their treatment. Researchers want to understand how treatments like surgery, radiation, and chemotherapy affect patients' oral health and overall well-being. They will collect information through questionnaires and clinical assessments at Ahmed Maher Teaching Hospital, focusing on factors like personal habits and the severity of any mouth-related side effects.
To participate, individuals must be between 65 and 74 years old, have completed their cancer treatment within the last year, and be able to complete a specific questionnaire. Participants should also have at least one molar and one central incisor to ensure proper oral health assessment. The study aims to gather insights that could improve oral care for head and neck cancer survivors, helping to enhance their quality of life. If selected, participants can expect to share their experiences and contribute to important research that may benefit future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • (HNC).
- • Completed cancer treatment (surgery, radiotherapy, and/or chemotherapy) within the past 12 months.
- • Attending routine follow-up visits at Ahmed Maher Teaching Hospital (AMTH), Egypt.
- • Able to communicate and complete the EORTC QLQ-H\&N35 questionnaire.
- • Presence of at least one molar and one central incisor in both upper and lower dentition (for oral hygiene assessment).
- • Provided written informed consent to participate in the study.
- Exclusion Criteria:
- • Patients with cognitive impairment or severe mental illness affecting their ability to respond to the questionnaire.
- • Patients with debilitating conditions (e.g., terminal illness, bedridden status).
- • Trismus (mouth opening \<20mm) preventing oral examination.
- • Patients who decline to participate or withdraw consent.
- • Patients with incomplete medical records or loss to follow-up.
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported